MENTICE
Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation's (MSC) Medical Products division. Mentice is the global leader of simulation-based performance solutions for endovascular therapies.
Under the agreement, Mentice will acquire the assets of the MSC’s Medical Products division in a share based transaction.
“With this transaction Mentice gains a very experienced US-based development organization, supporting our North American customers along with a portfolio of solutions that will be leveraged in the Mentice VIST® product line,” says Goran Malmberg, CEO of Mentice. “Furthermore, we are adding clinical training services, providing our clients with an even wider choice of offerings. I believe this will greatly benefit both our current and new customers, clearly demonstrating Mentice’s commitment in taking the market to the next level”.
Mentice will immediately assume responsibility for MSC’s clients and will provide continued support for the Compass AT and Compass 2 platforms along with associated software and iPad Apps. Mentice also plans to offer migration solutions to the Mentice VIST platform.
“This transaction enables MSC to focus our efforts on our Hospital Performance Improvement division (HPI) which is our main emphasis for the future”, says Mary Beth Loesch, President and CEO of MSC. In addition, Loesch added our HPI services include consulting, on-line courseware, and clinical pathway training for important topics such as Stroke and Sepsis. “We see many opportunities to collaborate where our services would complement the solutions provided by Mentice.”
About Mentice
Mentice is the world leader in virtual
reality‐based interventional medical simulation solutions. Our solutions
help healthcare professionals with skills acquisition, continuous
development and preprocedural planning—leading to improved productivity
and outcomes. Mentice solutions are scientifically validated, and have
been specifically developed for healthcare providers and the medical
industry. Neurovascular, cardiovascular and peripheral interventions are
just some of the areas covered by our systems. Learn more about the
features and benefits of Mentice solutions at: www.mentice.com
.
About MSC (Medical Simulation Corporation)
MSC is a global
healthcare leader in accelerating patient access to new medical
therapies, achieving the best patient outcomes, reducing patient
mortality and reducing the cost of healthcare delivery. MSC’s Advanced
Clinical Quality Solutions enable multi-disciplinary healthcare team
performance improvement, with a focus on standardizing care delivery and
creating clinical and cost-control results.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171220005546/en/
Contact:
Mentice AB
Hiral Chavda
Director Marketing
Communications
+46 (0) 705 88 86 10
hiral.chavda@mentice.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NY-DC-ADMINISTRATION28.3.2024 21:15:26 CET | Press release
DC Secretary Announces Annual Determinations Committees Outcome
CA-HTEC/G2-RISK28.3.2024 17:03:32 CET | Press release
Faster Recoveries, Improved Security: HTEC and G2 Risk Solutions Join Forces to Advance Bankruptcy Management
YCVB28.3.2024 16:01:31 CET | Press release
The reopening of the Yokohama Museum of Art adds another innovative and distinctive venue for events in Yokohama
CA-LAMBDATEST28.3.2024 16:01:31 CET | Press release
LambdaTest Launches The Phoenix Project, an Employee Resource Group for Women
YCVB28.3.2024 16:01:31 CET | Press release
Eight new sustainability-themed experiences—exclusive to Yokohama—for convention participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom